Correction: Association of cardiovascular outcomes with masked hypertension defined by home blood pressure monitoring in a Japanese general practice population (JAMA Cardiol (2018) DOI: 10.1001/jamacardio.2018.1233);Association of cardiovascular outcomes with masked hypertension defined by home blood pressure monitoring in a Japanese general practice population

JAMA Cardiology

Volumn 3, Issue 7, 2018, Pages 583-590

  Fujiwara, Takeshi ^a,b   Yano, Yuichiro ^c   Hoshide, Satoshi ^a   Kanegae, Hiroshi ^a,d   Kario, Kazuomi ^a  

^a JICHI MEDICAL UNIVERSITY   (Japan)

^b Higashi Agatsuma Machi National Health Insurance Clinic   (Japan)

^c UNIVERSITY OF MISSISSIPPI MEDICAL CENTER   (United States)

^d Genki Plaza Medical Center for Health Care ^*  (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; ANTIHYPERTENSIVE AGENT; BRAIN NATRIURETIC PEPTIDE; CREATININE;

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; BLOOD PRESSURE MEASUREMENT; BLOOD PRESSURE MONITORING; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CEREBROVASCULAR ACCIDENT; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; FOLLOW UP; GENERAL PRACTICE; HUMAN; HYPERTENSION; ISCHEMIC HEART DISEASE; JAPAN; JAPANESE (PEOPLE); MAJOR CLINICAL STUDY; MALE; MASKED HYPERTENSION; METABOLIC PARAMETERS; OBSERVATIONAL STUDY; OUTPATIENT; PRIMARY HEALTH CARE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; UNIVERSITY HOSPITAL; URINE ALBUMIN TO CREATININE RATIO; URINE LEVEL; WHITE COAT HYPERTENSION; BLOOD PRESSURE; CLINICAL TRIAL; COMPLICATION; CORONARY ARTERY DISEASE; INCIDENCE; MIDDLE AGED; MULTICENTER STUDY; PHYSIOLOGY; PROCEDURES; PROGNOSIS; RISK FACTOR; SURVIVAL RATE;

AGED; BLOOD PRESSURE; BLOOD PRESSURE MONITORING, AMBULATORY; CORONARY DISEASE; FEMALE; GENERAL PRACTICE; HUMANS; INCIDENCE; JAPAN; MALE; MASKED HYPERTENSION; MIDDLE AGED; PROGNOSIS; RISK FACTORS; STROKE; SURVIVAL RATE;

EID: 85051771880     PISSN: 23806583     EISSN: 23806591     Source Type: Journal    
DOI: 10.1001/jamacardio.2018.1880     Document Type: Erratum

References (46)

1. Kario K, Pickering TG, Umeda Y, et al. Morning surge in blood pressure as a predictor of silent and clinical cerebrovascular disease in elderly hypertensives. Circulation. 2003; 107(10):1401-1406.
2. Pickering TG, Shimbo D, Haas D. Ambulatory blood-pressure monitoring. N Engl J Med. 2006; 354(22):2368-2374.
3. Yano Y, Kario K. Nocturnal blood pressure and cardiovascular disease. Hypertens Res. 2012; 35(7): 695-701.
4. Shimbo D, Abdalla M, Falzon L, Townsend RR, Muntner P. Role of ambulatory and home blood pressure monitoring in clinical practice. Ann Intern Med. 2015; 163(9):691-700.
5. Banegas JR, Ruilope LM, de la Sierra A, et al. High prevalence of masked uncontrolled hypertension in people with treated hypertension. Eur Heart J. 2014; 35(46):3304-3312.
6. Naser N, Dzubur A, Durak A, Kulic M, Naser N. Blood pressure control in hypertensive patients, cardiovascular risk profile and the prevalence of masked uncontrolled hypertension (MUCH). Med Arch. 2016; 70(4):274-279.
7. Agarwal R, Pappas MK, Sinha AD. Masked uncontrolled hypertension in CKD. J AmSoc Nephrol. 2016; 27(3):924-932.
8. Pierdomenico SD, Pierdomenico AM, Coccina F, Porreca E. Prognosis of masked and white coat uncontrolled hypertension detected by ambulatory blood pressure monitoring in elderly treated hypertensive patients. Am J Hypertens. 2017; 30(11): 1106-1111.
9. Pickering TG, Eguchi K, Kario K. Masked hypertension: a review. Hypertens Res. 2007; 30(6): 479-488.
10. Yano Y, Oparil S. Masked hypertension. Curr Hypertens Rep. 2017; 19(10):81.
11. Bobrie G, Chatellier G, Genes N, et al. Cardiovascular prognosis of " masked hypertension" detected by blood pressure self-measurement in elderly treated hypertensive patients. JAMA. 2004; 291(11):1342-1349.
12. Tientcheu D, Ayers C, Das SR, et al. Target organ complications and cardiovascular events associated with masked hypertension and white-coat hypertension. J AmColl Cardiol. 2015; 66(20): 2159-2169.
13. Booth JN III, Diaz KM, Seals SR, et al. Masked hypertension and cardiovascular disease events in a prospective cohort of blacks. Hypertension. 2016; 68(2):501-510.
14. Imai Y, Obara T, Asamaya K, Ohkubo T. The reason why home blood pressure measurements are preferred over clinic or ambulatory blood pressure in Japan. Hypertens Res. 2013; 36(8):661-672.
15. Stergiou GS, Asayama K, Thijs L, et al; International Database on Home Blood Pressure in Relation to Cardiovascular Outcome (IDHOCO) Investigators. Prognosis of white-coat and masked hypertension: International Database of Home Blood Pressure in Relation to Cardiovascular Outcome. Hypertension. 2014; 63(4):675-682.
16. Kotsis V, Stabouli S, Toumanidis S, et al. Target organ damage in " white coat hypertension" and " masked hypertension". Am J Hypertens. 2008; 21 (4):393-399.
17. Sharman JE, Hare JL, Thomas S, et al. Association of masked hypertension and left ventricular remodeling with the hypertensive response to exercise. Am J Hypertens. 2011; 24(8): 898-903.
18. Hönninen MR, Niiranen TJ, Puukka PJ, Kesöniemi YA, Köhönen M, Jula AM. Target organ damage and masked hypertension in the general population. J Hypertens. 2013; 31(6):1136-1143.
19. Diaz KM, Veerabhadrappa P, Brown MD, Whited MC, Dubbert PM, Hickson DA. Prevalence, determinants, and clinical significance of masked hypertension in a population-based sample of African Americans. Am J Hypertens. 2015; 28(7): 900-908.
20. Hoshide S, Yano Y, Haimoto H, et al; J-HOP Study Group. Morning and evening home blood pressure and risks of incident stroke and coronary artery disease in the Japanese general practice population. Hypertension. 2016; 68(1):54-61.
21. Weir MR. Microalbuminuria and cardiovascular disease. Clin J AmSoc Nephrol. 2007; 2(3):581-590.
22. Pikula A, Beiser AS, DeCarli C, et al. Multiple biomarkers and risk of clinical and subclinical vascular brain injury. Circulation. 2012; 125(17): 2100-2107.
23. Shimamoto K, Ando K, Fujita T, et al; Japanese Society of Hypertension Committee for Guidelines for the Management of Hypertension. The Japanese Society of Hypertension guidelines for the management of hypertension (JSH 2014). Hypertens Res. 2014; 37(4):253-390.
24. Anwar YA, Giacco S, McCabe EJ, Tendler BE, White WB. Evaluation of the efficacy of the Omron HEM-737 IntelliSense device for use on adults according to the recommendations of the Association for the Advancement of Medical Instrumentation. Blood Press Monit. 1998; 3(4): 261-265.
25. Beck AT, Ward CH, Mendelson M, Mock J, Erbaugh J. An inventory for measuring depression. Arch Gen Psychiatry. 1961; 4:561-571.
26. Holm S. A simple sequentially rejective multiple test procedure. Scand J Stat. 1979; 6(2):65-70.
27. Chobanian AV, Bakris GL, Black HR, et al; National Heart, Lung, and Blood Institute Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure; National High Blood Pressure Education Program Coordinating Committee. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. JAMA. 2003; 289(19): 2560-2572.
28. D'Agostino RB Sr, Vasan RS, Pencina MJ, et al. General cardiovascular risk profile for use in primary care. Circulation. 2008; 117(6):743-753.
29. Ohkubo T, Imai Y, Tsuji I, et al. Home blood pressure measurement has a stronger predictive power for mortality than does screening blood pressure measurement. J Hypertens. 1998; 16(7): 971-975.
30. Niu K, Hozawa A, Awata S, et al. Home blood pressure is associated with depressive symptoms in an elderly population aged 70 years and over. Hypertens Res. 2008; 31(3):409-416.
31. Stergiou GS, Baibas NM, Kalogeropoulos PG. Cardiovascular risk prediction based on home blood pressure measurement. J Hypertens. 2007; 25(8): 1590-1596.
32. Niiranen TJ, Hönninen MR, Johansson J, Reunanen A, Jula AM. Home-measured blood pressure is a stronger predictor of cardiovascular risk than office blood pressure. Hypertension. 2010; 55(6):1346-1351.
33. Schettini C, Bianchi M, Nieto F, Sandoya E, Senra H; HypertensionWorking Group. Ambulatory blood pressure: normality and comparison with other measurements. Hypertension. 1999; 34(4, pt 2):818-825.
34. Ogedegbe G, Agyemang C, Ravenell JE. Masked hypertension: evidence of the need to treat. Curr Hypertens Rep. 2010; 12(5):349-355.
35. Schoenthaler AM, Schwartz J, Cassells A, Tobin JN, Brondolo E. Daily interpersonal conflict predicts masked hypertension in an urban sample. Am J Hypertens. 2010; 23(10):1082-1088.
36. Trudel X, Brisson C, Milot A. Job strain and masked hypertension. Psychosom Med. 2010; 72(8): 786-793.
37. Uzu T, Nakao K, Kume S, et al. High sodium intake is associated with masked hypertension in Japanese patients with type 2 diabetes and treated hypertension. Am J Hypertens. 2012; 25(11):1170-1174.
38. Cacciolati C, Tzourio C, Hanon O. Blood pressure variability in elderly persons with white-coat and masked hypertension compared to those with normotension and sustained hypertension. Am J Hypertens. 2013; 26(3):367-372.
39. Kayano H, Koba S, Matsui T, et al. Impact of depression on masked hypertension and variability in home blood pressure in treated hypertensive patients. Hypertens Res. 2015; 38(11):751-757.
40. Kario K, Chen CH, Park S, et al. Consensus document on improving hypertension management in Asian patients, taking into account Asian characteristics. Hypertension. 2018; 71(3):375-382.
41. Niiranen TJ, Asayama K, Thijs L, et al; International Database of Home Blood Pressure in Relation to Cardiovascular Outcome Investigators. Outcome-driven thresholds for home blood pressure measurement: International Database of Home Blood Pressure in Relation to Cardiovascular Outcome [published correction appears in Hypertension. 2014; 63(4):e91]. Hypertension. 2013; 61(1):27-34.
42. Task Force CPS. Self-measured blood pressure monitoring improves outcomes: recommendation of the Community Preventive Services Task Force. Am J Prev Med. 2017; 53(3):e115-e118.
43. Whelton PK, Carey RM, AronowWS, et al. 2013 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines [published online November 13, 2017]. Hypertension. doi:10.1161/HYP .0000000000000066
44. Kario K. Global impact of 2017 American Heart Association/American College of Cardiology hypertension guidelines. Circulation. 2018; 137(6): 543-545.
45. Kario K. Evidence and perspectives on the 24-hour management of hypertension: hemodynamic biomarker-initiated " anticipation medicine" for zero cardiovascular event. Prog Cardiovasc Dis. 2016; 59(3):262-281.
46. Kario K, Tomitani N, Kanegae H, et al. Development of a new ICT-based multisensor blood pressure monitoring system for use in hemodynamic biomarker-initiated anticipation medicine for cardiovascular disease: the national IMPACT program project. Prog Cardiovasc Dis. 2017; 60(3):435-449.